Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» CRISPR Therapeutics
CRISPR Therapeutics
Where Will CRISPR Therapeutics Be in 10 Years?
Motley Fool
Tue, 12/15/20 - 10:44 am
CRISPR
CRISPR Therapeutics
Red-Hot Biotechs to Take Spotlight at Blood Disorder Meeting
Yahoo/Bloomberg
Fri, 12/4/20 - 11:09 am
ASH2020
Trillium Therapeutics
CRISPR Therapeutics
Fate Therapeutics
Vertex Pharmaceuticals
CRISPR and Vertex Release Additional Data for Blood Disease Treatment
Motley Fool
Wed, 11/4/20 - 10:50 pm
CRISPR Therapeutics
CRISPR
Vertex Pharmaceuticals
CTX001
beta thalassemia
sickle cell disease
Despite Recent Bad News, Here's Why CRISPR Is Primed to Explode
Motley Fool
Mon, 11/2/20 - 10:20 am
CRISPR
CRISPR Therapeutics
clinical trials
CRISPR stock slides as CAR-T death overshadows signs of efficacy
Fierce Biotech
Wed, 10/21/20 - 10:54 am
CRISPR
CRISPR Therapeutics
CAR-T
patient deaths
Where Will CRISPR Therapeutics Be in 5 Years?
Motley Fool
Fri, 07/17/20 - 10:53 am
CRISPR Therapeutics
Biopharma Companies Continue to Expand, Add Jobs Despite Ongoing Pandemic
BioSpace
Tue, 06/30/20 - 11:44 pm
pharma industry
biotech
pandemic
COVID-19
hirings
AGC Biologics
Grail
Grifols
CRISPR Therapeutics
Sana Biotechnology
Point
Sanofi
Medpharm
Regeneron
CRISPR and Vertex show durability of gene-editing therapy, hoping for one and done treatment
Fierce Biotech
Mon, 06/15/20 - 10:35 am
Vertex Pharmaceuticals
CRISPR Therapeutics
CTX001
gene editing
sickle cell disease
beta thalassemia
New CRISPR, gene therapy results strengthen potential for treatment of blood diseases
BioPharma Dive
Fri, 06/12/20 - 11:11 am
CRISPR
gene therapy
beta thalassemia
sickle cell disease
CRISPR Therapeutics
Vertex
Bluebird Bio
EHA
Derailed by the pandemic, FDA offers CRISPR, Vertex drug program VIP status for its comeback play
Endpoints
Mon, 05/11/20 - 10:16 am
CRISPR Therapeutics
Vertex Pharmaceuticals
CTX001
pandemic
COVID-19
CRISPR Therapeutics braces for 'severe impact' from COVID-19 crisis
Fierce Biotech
Wed, 04/1/20 - 09:54 am
CRISPR
CRISPR Therapeutics
COVID-19
clinical trials
Here's Why CRISPR Stocks Fell in January
Motley Fool
Wed, 02/5/20 - 10:07 am
Intellia Therapeutics
CRISPR Therapeutics
Editas Medicine
CRISPR
3 Biotech Start-Ups That Could Soar in 2020
Motley Fool
Mon, 01/27/20 - 10:50 am
Cue Biopharma
Rubius Therapeutics
CRISPR Therapeutics
More CRISPR Stock Catalysts Ahead
Motley Fool
Mon, 11/25/19 - 09:38 am
gene editing
CRISPR
Editas Medicine
Intellia Therapeutics
CRISPR Therapeutics
Biotech Stock Pops On Promising First In-Human CRISPR Gene-Editing Drug
Investors Business Daily
Wed, 11/20/19 - 09:53 am
CRISPR Therapeutics
gene editing
CRISPR
beta thalassemia
sickle cell disease
That $335M JV Bayer set up on CRISPR/Cas9? They’re letting the biotech partner carry on
Endpoints
Mon, 10/21/19 - 04:34 pm
Bayer
CRISPR Therapeutics
CRISPR-Cas9
Gene Therapy vs. Gene Editing: Which Is Better for Tackling Muscular Dystrophy?
Motley Fool
Sun, 06/9/19 - 01:41 pm
gene editing
gene therapy
DMD
Duchenne Muscular Dystrophy
Vertex Pharmaceuticals
CRISPR Therapeutics
Exonics
Vertex sets sights on DMD gene therapy, joining crowded field
Biopharma Dive
Fri, 06/7/19 - 10:17 am
Vertex Pharmaceuticals
DMD
M&A
CRISPR Therapeutics
Exonics
gene therapy
Should Sangamo's Failure Make CRISPR Investors Nervous?
Motley Fool
Sun, 02/10/19 - 01:52 pm
Sangamo Therapeutics
gene editing
CRISPR
CRISPR Therapeutics
Editas Medicine
Where Will CRISPR Therapeutics Be in 10 Years?
Motley Fool
Sun, 01/13/19 - 11:34 am
CRISPR
gene editing
CRISPR Therapeutics
Pages
« first
‹ previous
1
2
3
4
5
next ›
last »